Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 USD | 0.00% | +2.50% | +0.82% |
2023 | Global Cord Blood Corporation Announces Board Appointments | CI |
2023 | Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index | CI |
Sales 2021 | 1.16B 160M | Sales 2022 | 1.24B 172M | Capitalization | 2.97B 410M |
---|---|---|---|---|---|
Net income 2021 | 508M 70.1M | Net income 2022 | 501M 69.13M | EV / Sales 2021 | -2.13 x |
Net cash position 2021 | 6.07B 838M | Net cash position 2022 | 6.66B 919M | EV / Sales 2022 | -2.97 x |
P/E ratio 2021 |
7.1
x | P/E ratio 2022 |
5.93
x | Employees | 1,202 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.41% |
1 week | +2.50% | ||
Current month | +2.50% | ||
1 month | -1.60% | ||
3 months | -18.00% | ||
6 months | +2.50% | ||
Current year | +0.82% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 08-12-31 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 04-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 08-12-31 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Director/Board Member | 56 | 08-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.23 | 0.00% | 5,368 |
24-06-06 | 1.23 | +2.50% | 8,429 |
24-05-31 | 1.2 | +7.14% | 2,300 |
Delayed Quote OTC Markets, June 07, 2024 at 03:37 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+0.82% | 165M | |
+24.66% | 88.38B | |
-21.76% | 77.56B | |
+1.76% | 26.97B | |
+7.94% | 18.45B | |
-13.50% | 16.57B | |
+3.23% | 15.81B | |
+77.51% | 13.65B | |
+76.96% | 13.06B | |
+23.02% | 12.55B |
- Stock Market
- Equities
- CORBF Stock